Research Summary
Research Summary
Drivers of market entry
Description
In this paper, I look at the selection of markets for entry. Specifically, regulation in the US pharmaceutical industry allows generic firms to try and enter the market prior to the expiration of patents. This work aims to understand what drives market entry, specifically where the entrant is a non-traditional competitor (here, a generic entrant seeking to compete with a branded pharmaceutical firm). I will also examine whether firms develop specific capabilities in challenging patents.
Last updated: 5 July 2007
Last updated: 5 July 2007